Astria Therapeutics, Inc. (ATXS) Tops Q2 EPS by 2c

Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q2 EPS of ($0.45), $0.02 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• KULR Technology Group (KULR) Misses Q2 EPS by 39c
• Dare Bioscience (DARE) Tops Q2 EPS by 11c